Multicenter Outcomes for Catheter Ablation of Idiopathic Premature Ventricular Complexes
Overview
Authors
Affiliations
Objectives: This study reports multicenter outcomes and complications for catheter ablation of premature ventricular complexes (PVCs) and investigates predictors of procedural success, as well as development of PVC-induced cardiomyopathy.
Background: Catheter ablation of frequent idiopathic PVCs is used to eliminate symptoms and treat PVC-induced cardiomyopathy. Large-scale multicenter outcomes and complication rates have not been reported.
Methods: This retrospective cohort study included 1,185 patients (55% female; mean age 52 ± 15 years; mean ejection fraction 55 ± 10%; mean PVC burden 20 ± 13%) who underwent catheter ablation for idiopathic PVCs at 8 centers between 2004 and 2013. The following factors were evaluated: patient demographics, procedural characteristics, complication rates, and clinical outcomes.
Results: Acute procedural success was achieved in 84% of patients. In centers at which patients were followed up routinely with post-ablation Holter monitoring, continued success at clinical follow-up without use of antiarrhythmic drugs was 71%. Including the use of antiarrhythmic medications, the success rate at a mean of 1.9 years of follow-up was 85%. In a multivariate analysis, the significant predictors of acute success were PVC location and number of distinct PVC configurations (p < 0.03). The only significant predictor of continued success at clinical follow-up was a right ventricular outflow tract PVC location (p < 0.01). In 245 patients (21%) with PVC-induced cardiomyopathy, the mean ejection fraction improved from 38% to 50% (p < 0.01) after ablation. Independent predictors for development of PVC-induced cardiomyopathy were male gender, PVC burden, lack of symptoms, and epicardial PVC origin (p < 0.05). The overall complication rate was 5.2% (2.4% major complications and 2.8% minor complications), and complications were most commonly related to vascular access (2.8%). There was no procedure-related mortality.
Conclusions: Catheter ablation of frequent PVCs is a low-risk and often effective treatment strategy to eliminate PVCs and associated symptoms. In patients with PVC-induced cardiomyopathy, cardiac function is frequently restored after successful ablation.
Rodkiewicz D, Momot K, Kozluk E, Piatkowska A, Kwasiborski P, Buksinska-Lisik M Postepy Kardiol Interwencyjnej. 2025; 20(4):474-479.
PMID: 39897020 PMC: 11783260. DOI: 10.5114/aic.2024.142618.
Allam L, Nabih M, Basyouni Helal M, Allam A, Ali A Pediatr Cardiol. 2025; .
PMID: 39893615 DOI: 10.1007/s00246-025-03784-x.
Idiopathic Annular Ventricular Arrhythmias.
Yoneda Z, Stevenson W Arrhythm Electrophysiol Rev. 2025; 13:e21.
PMID: 39764086 PMC: 11702011. DOI: 10.15420/aer.2024.40.
Verhaeghe L, Vijgen J, Benit E, Bijnens E, Vanrusselt J, Dilling-Boer D HeartRhythm Case Rep. 2024; 10(10):706-709.
PMID: 39664857 PMC: 11628800. DOI: 10.1016/j.hrcr.2024.07.003.
Aldrich J, Daniels Z, Eisner M, Kistler I, Bowman J, Hor K Pediatr Cardiol. 2024; .
PMID: 39532707 DOI: 10.1007/s00246-024-03683-7.